Willow Grove, PA, United States of America

Andrew B Benowitz

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew B Benowitz. Retrieved from https://idiyas.com/inventor/andrew-b-benowitz-vgllp2ib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrew B. Benowitz

Introduction

Andrew B. Benowitz is a notable inventor based in Willow Grove, PA (US). He has made significant contributions to the field of synthetic chemistry, particularly through his innovative work on oxazolidinones. His research focuses on developing synthetic methods for pyrrolinone-based compounds that can mimic or inhibit the biological and chemical activity of peptides.

Latest Patents

Andrew B. Benowitz holds 1 patent for his invention titled "Oxazolidinones and methods for the synthesis and use of same." This patent outlines synthetic methods that are crucial for the development of compounds with potential therapeutic applications.

Career Highlights

Benowitz is affiliated with the University of Pennsylvania, where he continues to advance his research in synthetic methods. His work has garnered attention for its potential implications in medicinal chemistry and drug development.

Collaborations

Throughout his career, Andrew has collaborated with esteemed colleagues such as Amos B. Smith, III, and Ralph F. Hirschmann. These partnerships have enriched his research and contributed to the advancement of synthetic methodologies.

Conclusion

Andrew B. Benowitz exemplifies the spirit of innovation in the field of synthetic chemistry. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…